3D Systems plans to sell its medical simulation business, Simbionix, to a Swedish supplier of reality simulators for medical training.
Surgical Science Sweden AB will acquire the business for a purchase price of US$305 million, the company said. Simbionix reported sales in 2020 of US$40.8 million.
According to 3D Systems, this move will complete its strategy to divest non-core businesses to focus on additive manufacturing (AM).
‘As the Simbionix team now joins forces with Surgical Science, I believe their future will be even brighter, with increased scale and an ability to leverage the core strengths of both businesses in a growing medical simulation market,’ said Dr Jeffrey Graves, president & CEO, 3D Systems. ‘Having reorganized the company into two business units – Healthcare and Industrial Solutions – and restructured to drive operational efficiencies over the last year, we now move forward expecting strong organic growth and profitability.’
This story uses material from 3D Systems, with editorial changes made by Materials Today.
